TheGridNet
The Melbourne Grid Melbourne

Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis

MELBOURNE, Australia, Oct. 23, 2023 /PRNewswire/ -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces that the U.S. Food

Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis

Опубликовано : 2 года назад от PR Newswire в Business Health

Sports editor Jake Dowling and sports reporter Logan Farlow sit down to recap week 8 and preview week 9 as the playoff races heat up. Recaps: 1:15-17:32 Sweeny 42, Columbia 7, 18:09 Iowa Colony 37, Navasota 21, 27:00 Brazosport vs Stafford, 33:25 Brazosport Christian 76, Logos Prep 28, …


Темы: FDA

Read at original source